Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?

EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?

FromEASL Podcasts


EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?

FromEASL Podcasts

ratings:
Length:
31 minutes
Released:
Apr 5, 2022
Format:
Podcast episode

Description

Discover this EASL Studio podcast discussing the Baveno Consensus started over 30 years ago with the aim of reviewing current diagnostic and therapeutic strategies and producing updated definitions.But, with the extension of indication of non-steroidal beta blockers, has the consensus gone too far?Is there enough evidence for their use in already decompensated patients?How safe are they in this patient population?What do we know about the effects on refractory ascites? Circulatory dysfunction?Read moreAll EASL Studio Podcasts are available on EASL Campus.
Released:
Apr 5, 2022
Format:
Podcast episode

Titles in the series (87)

The EASL Podcast collection includes educational podcasts and audio versions of digital EASL offerings. The ASK EASL Podcasts: Ongoing series of educational podcasts. EASL Studio: Your weekly hepatology broadcast news.